RecruitingNCT06506942
TRICURE EFS
The TRICURE EFS Study
AI Description
Prospective, multi-center study to assess safety and performance of the TRiCares Topaz Tricuspid Valve Replacement System
- Who can join
- adult, older adult
- Participants
- 15
- Expected completion
- 2031-03
- Funded by
- industry
Conditions studied
Cardiovascular Diseases, Heart Valve Diseases, Tricuspid Valve Regurgitation
What is being tested
- DEVICE: Transcatheter Tricuspid Valve Replacement
What it measures
- Composite of MAE, Composite rate of major adverse events (MAEs) at 30 days, including mortality, myocardial infarction, stroke and major complications., 30 day post-intervention
- Device Success, Device success defined as a reduction in tricuspid regurgitation immediately post-intervention, immediately post-intervention
Centers Participating
These centers are participating in this study. Reach out to them directly to learn more.
Registry entry updated 2026-07-23
Deciding whether to join a study is your choice, and you can ask a study team questions before you decide anything.
If you would rather we did it with you, call us on (656) 206-4686.